Cortiment: first budesonide tablet for ulcerative colitis

Cortiment is taken as a single tablet once daily for up to 8 weeks.
Cortiment is taken as a single tablet once daily for up to 8 weeks.

Cortiment (budesonide) 9mg prolonged-release tablets are now available from Ferring, for the induction of remission in mild to moderate active ulcerative colitis where mesalazine is not sufficient. A single tablet is taken once daily for up to 8 weeks.

In the CORE I study in 509 patients with active mild to moderate ulcerative colitis, 2.4 times more patients achieved clinical remission with the prolonged-release budesonide tablets than with placebo (17.9% vs 12.1%, p=0.0143) and rates of adverse events were similar.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more